December 30, 2021 Sophia Vida
Biotech & Pharma

Biogen Shares Explode on Talks that Company is to be Bought by Samsung

In a deal valued at potentially over $40 billion, rumors surfaced that Biogen may be acquired by Samsung. Shares of the U.S. based drug maker soared 8.9% in afternoon trading on Wednesday after the Korea Economic Daily reported that Biogen is in talks to be acquired by South Korea-based conglomerate Samsung Group. Citing investment banking … Continue reading “Biogen Shares Explode on Talks that Company is to be Bought by Samsung”